Advertisement

Topics

BioXcel Therapeutics Inc BTAI Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250

13:34 EDT 13 Oct 2018 | BioPortfolio Reports

Summary


BioXcel Therapeutics Inc BioXcel Therapeutics a subsidiary of BioXcel Corp is a clinical stage biopharmaceutical company focused on novel artificial intelligencebased drug development in the fields of neuroscience and immunooncology. Its pipeline product portfolio includes BXCL501, an adrenergic agent with a sublingual route of administration is used for treating neuropsychiatric and neurodegenerative diseases; BXCL701, an immunooncology agent designed for the treatment of prostate and pancreatic cancers; BXCL502, a novel approach to the treatment of symptoms resulting from neurological disorders; and BXCL702, an immunooncology intravenous compound for hematological malignancies. The company's drug reinnovation approach leverages existing approved drugs and/or clinically validated product candidates with big data and proprietary machine learning algorithms to develop new therapeutic candidates. BioXcel Therapeutics is headquartered in New Haven, Connecticut, the US.


BioXcel Therapeutics Inc BTAI Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions.


GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research.


Scope


Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector.

Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios.

Business Description A brief description of the company's operations.

Key Employees A list of the key executives of the company.

Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors A list of the key competitors of the company.

Key Recent Developments A brief on recent news about the company.


Reasons to Buy


Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.


Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.


Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.


Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.


Stay uptodate on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.


Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.


Note*: Some sections may be missing if data is unavailable for the company.

Original Article: BioXcel Therapeutics Inc BTAI Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250

NEXT ARTICLE

More From BioPortfolio on "BioXcel Therapeutics Inc BTAI Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...